FGF1 and Hyperglycemia: These results suggest that under hyperglycaemia condition, enhanced IL‐10 level is an adaptive response to resist the body's inflammation, and FGF1 administration further promotes the secretion of anti‐inflammatory cytokines (IL‐10).